Evidence map›Paper›PMID 41204315›Full record

ReviewHereditary cancer in clinical practice2025

The genetic puzzle of FAP: exploring novel diagnostic approaches for APC/MUTYH-negative case.

Natalia Grot, Marek Kazimierczyk, Marcin Szuman, Marta Kaczmarek-Ryś, Alicja Kryszczyńska, Iga Dziechciowska, Monika Knaur, Andrzej Hnatyszyn, Szymon Hryhorowicz, Andrzej Pławski

Abstract readReview
In one paragraph

Review in Hereditary cancer in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Natalia GrotPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Marek KazimierczykPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Marcin SzumanPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Marta Kaczmarek-RyśPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Alicja KryszczyńskaPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Iga DziechciowskaPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Monika KnaurPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Andrzej HnatyszynIndependent Public Health Care Centre in Nowa Sól, Multispecialty Hospital, Nowa Sól, 67-100, Poland.
Szymon HryhorowiczPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland.
Andrzej PławskiPolish Academy of Sciences, Institute of Human Genetics, Strzeszyńska 32, Poznań, 60-479, Poland. andrzej.plawski@igcz.poznan.pl.

Funding

Minister of Education and Science NdS-II/SP/0139/2024/01
6 · The paper itself

Abstract

Multiple polyposis syndromes include Familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome (PJS), Juvenile polyposis syndrome (JPS), PTEN hamartoma tumor syndrome (PHTS), MUTYH-associated polyposis (MAP), NTHL1-associated polyposis (NAP), Polymerase proofreading-associated polyposis (PPAP), and MBD4-associated polyposis. Common to these syndromes is the presence of polyps in the large intestine and very high risk of developing colorectal cancer (CRC), which can reach up to 100% in the case of FAP. The development of FAP is associated with pathogenic variants of the APC gene. However, pathogenic variants are not always detected in patients with FAP, which poses a significant clinical challenge for both patients and their families, who may be at increased risk for developing the disease. A second strong predisposition to CRC is MAP, characterized by biallelic pathogenic variants in the MUTYH gene, with a phenotype similar to FAP. This mini review focuses on potential approaches to improve the diagnosis of patients in whom pathogenic variants in the APC and MUTYH genes are not detected by routine testing.

Indexed as

APCColorectal cancerFAPMUTYHPolyposis

Identifiers

PMID41204315
PMCPMC12595752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.